Advertisement
Regulators Discuss Approval of New Alzheimer Disease Drug

Tagrisso Approved as Adjuvant Therapy for NSCLC With EGFR Mutations

0

Current approval of the once-daily tablet indicated for patients who have undergone complete tumor removal

CDC: Life Expectancy for U.S. Population Increased in 2019

0

And age-adjusted rate of drug overdose deaths increased from 20.7 to 21.6 per 100,000 from 2018 to 2019

ACR: Warfarin Tied to Increased Risk for Knee

Buprenorphine Rx Fills for OUD Plateau During Pandemic

0

Cash-paid prescriptions declined significantly, but no significant changes seen in those paid by public or private insurance

Los confinamientos podrían estar manteniendo a raya a los ataques de asma de los niños

Dietary Advanced Glycation End-Product Intake, Wheezing Linked

0

Higher AGE intake associated with wheeze-disrupted sleep and exercise, wheezing requiring prescription meds in children

For Spanish Translation

FDA Issues EUA for Moderna COVID-19 Vaccine

0

On Sunday, ACIP voted to recommend frontline workers and those ages 75 years and older be included in next phase of vaccine distribution

Hormonal Contraceptives Linked to Decline in Asthma Exacerbation

Oral Contraceptives Protect Against Ovarian, Endometrial Cancer

0

Increased risk for breast cancer observed, which was seen for up to two years after discontinuation of oral contraceptives

Rimegepant Bests Placebo for Preventing Migraine

0

Mean number of migraine days per month lower in those receiving rimegepant versus placebo

La pérdida del olfato es más común de lo que se pensaba en la COVID-19

Antibody Cocktail Enhances Clearance of SARS-CoV-2 Virus

0

Cocktail of two antibodies against SARS-CoV-2 spike protein reduces viral load, with greater effect in antibody-negative patients

Low U.S. Flu Rates Seen as Pandemic Rages

0

Many more people are getting flu shots to avoid the risk for getting both the flu and COVID-19

Radiation Rx for Prostate Cancer Can Cause Financial Pain: Study

FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer

0

Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone